Zhejiang Hisun Pharmaceutical
China Updated 9 July 2026
Zhejiang Hisun Pharmaceutical is an API manufacturer based in China. It holds 16 valid CEPs across a filed portfolio of 20 molecules. Its GMP standing is certified by MFDS (Korea) and EMA.
1
filings
across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.
Registered plants
| Site | FDA FEI |
| Taizhou, China | Not on file |
| Taizhou City, China | Not on file |
What they file, and where
| Molecule | Regulators | Docs |
| Ivermectin | EDQM | 2 |
| Acarbose | EDQM | 1 |
| Adenosine | EDQM | 1 |
| Bleomycin | SFDA (Saudi Arabia) | 1 |
| Bleomycin Sulfate | EDQM | 1 |
| Cytarabine | SFDA (Saudi Arabia) | 1 |
| Dactinomycin | SFDA (Saudi Arabia) | 1 |
| Daunorubicin | EDQM | 1 |
| Doxorubicin | EDQM | 1 |
| Doxorubicin Hydrochloride | EDQM | 1 |
Show all 20 molecules on file
| Epirubicin | EDQM | 1 |
| Lovastatin | EDQM | 1 |
| Methotrexate | SFDA (Saudi Arabia) | 1 |
| Milbemycin Oxime For Veterinary Use | EDQM | 1 |
| Mitomycin | EDQM | 1 |
| Pravastatin | EDQM | 1 |
| Simvastatin | EDQM | 1 |
| Ticagrelor | EDQM | 1 |
| Tigecycline | EDQM | 1 |
| Vinorelbine | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| MINSA (CR) | 1 | None |
| MFDS (Korea) | None | 2 |
| EMA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Zhejiang Hisun Pharmaceutical comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates